title: Arabinogalactan and lipoarabinomannan biosynthesis: structure, biogenesis and their potential as drug targets.
abstract: Mycobacterium tuberculosis, the etiological agent of TB, remains the leading cause of mortality from a single infectious organism. The persistence of this human pathogen is associated with its distinctive lipid-rich cell wall structure that is highly impermeable to hydrophilic chemical drugs. This highly complex and unique structure is crucial for the growth, viability and virulence of M. tuberculosis, thus representing an attractive target for vaccine and drug development. It contains a large macromolecular structure known as the mycolyl-arabinogalactan-peptidoglycan complex, as well as phosphatidyl-myo-inositol derived glycolipids with potent immunomodulatory activity, notably lipomannan and lipoarabinomannan. These cell wall components are often the targets of effective chemotherapeutic agents against TB, such as ethambutol. This review focuses on the structural details and biosynthetic pathways of both arabinogalactan and lipoarabinomannan, as well as the effects of potent drugs on these important (lipo)polysaccharides.
authors.affiliation: School of Biosciences, University of Birmingham, Edgbaston, Birmingham, B15 2TT, UK.
authors.forename: Monika
authors.initials: M
authors.lastname: Jankute
authors.forename: Shipra
authors.initials: S
authors.lastname: Grover
authors.forename: Amrita K
authors.initials: AK
authors.lastname: Rana
authors.forename: Gurdyal S
authors.initials: GS
authors.lastname: Besra
mesh_terms: D000818:Animals; D000995:Antitubercular Agents / Q000494:pharmacology; D002473:Cell Wall / Q000737:chemistry / Q000187:drug effects / Q000378:metabolism; D005685:Galactans / Q000037:antagonists & inhibitors / Q000096:biosynthesis* / Q000737:chemistry; D006801:Humans; D008070:Lipopolysaccharides / Q000037:antagonists & inhibitors / Q000096:biosynthesis* / Q000737:chemistry; D009169:Mycobacterium tuberculosis / Q000187:drug effects / Q000235:genetics / Q000378:metabolism*; D014376:Tuberculosis / Q000188:drug therapy / Q000382:microbiology
chemical_list: D000995:Antitubercular Agents; D005685:Galactans; D008070:Lipopolysaccharides; C050016:lipoarabinomannan; C005653:arabinogalactan